These results indicate that CD8+ T and B220+ B cells are activated in the late stages of lymphedema, whereas CD4+ T cells, which are important for lymphedema progression, infiltrate the lymphedema tissue earlier than other acquired immune cell activation. The gene discussed is PTPRC; the disease is lymphedema.